Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...

Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $50.46, demonstrating a -3.02% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered ...

Hims & Hers Health Inc. board members and executives failed to tell shareholders that its Novo Nordisk A/S Wegovy ...

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 13 Best Booming Stocks to Buy Now. On July 9, the digital health and ...

Savannah Chrisley shared details surrounding her past liposuction procedure, after the ‘Chrisley Knows Best’ star gained ...

Oscar-winning actress Lupita Nyong’o is sharing about her experience of being diagnosed with uterine fibroids, using the ...

The stigma didn’t end in the store, either. Winfrey has shared that people have felt free to comment about her weight ...

Gisele Fetterman opened up about her childhood as an undocumented immigrant and being mistaken for "the help" in her new book ...

Hims & Hers Health reports 111% Q1 2025 revenue growth to $586M, driven by personalized treatments & strong margins. Read why ...

Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug ...

After a bad breakup, writer Melissa Febos decided to abstain from sex and dating for a year. She didn't realize how much it ...

"She doesn’t have much of a support system nearby, and she’s not in good health and can’t get around well at all." ...